Northern Trust’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
DM
SCM
HA
FBIL
Northern Trust's LEGN Position: Q1 2026 in Review
Northern Trust increased its Legend Biotech (LEGN) stake by 1.5% in Q1 2026, buying an estimated $78.3K and bringing the position to 280,226 shares worth $5.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2451.
Northern Trust first reported a position in LEGN in Q1 2022 and has held it in 17 quarters since. The position peaked at $9.95M in Q2 2023. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.
- Northern Trust held 280,226 shares of Legend Biotech worth $5.07M as of Q1 2026.
- Northern Trust bought 4,107 Legend Biotech shares in Q1 2026, an estimated $78.3K.
- Legend Biotech made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2451 holding.
- Northern Trust first reported a position in Legend Biotech in Q1 2022 and has held it in 17 quarters since.
- Northern Trust's Legend Biotech position peaked at $9.95M in Q2 2023.
- 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.